Brief: Genovis Enters Into License Agreement With U.S. Biotech Company
25/03/2026 07:33
March 25 (Reuters) - Genovis AB GENOb.ST: ENTERS NON-EXCLUSIVE LICENSE AGREEMENT FOR ENDOS2 ENZYME TECHNOLOGY FOR ANTIBODY-DRUG CONJUGATE (ADC) DEVELOPMENT AND COMMERCIALIZATION LICENSE ENABLES RESEARCH, DEVELOPMENT, MANUFACTURE, AND COMMERCIALIZATION OF ADC PRODUCTS ACROSS ALL INDICATIONS Source text: ID:nMFN7d1cMP Further company coverage: [GENOb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))